HOME >> BIOLOGY >> NEWS
Inhibition Of A Novel Gene Involved In Phosphorylating Starch In TransgenicPotato Tubers Leads To The Repression Of Cold Induced Sweetening

Scientists at the Max Planck Institute of Molecular Plant Physiology in Golm, Germany, have isolated a novel gene that is responsible for the phosphorylation of starch. The effects which occur if the expression of this gene is inhibited are described in the May issue of Nature Biotechnology.

Starch is composed of amylose and amylopectin, which are slightly or more highly branched glucose polymers. In addition, amylopectin can, depending on the plant organ where it is manufactured, contain different levels of phosphate monoesters. The phosphate content in potato tubers is exceptionally high as compared with other plant storage organs. Starch biosynthesis is accomplished by different forms of starch synthase which polymerize the glucose monomers using ADP-glucose, and isoforms of branching enzyme which introduce the branch points. Other enzymes are needed to determine the final starch structure, e.g. the presence of a debranching enzyme is a prerequisite to synthesize the semi-crystalline starch granules in contrast to non-crystalline glycogen, which accumulates in eukaryotes other than plants, in bacteria, or in mutants of different plant species lacking this enzyme.

Even though many starch biosynthetic enzymes are known, it has never been possible to synthesize semi-crystalline glucans in vitro, nor has it been explained how the phosphate monoesters are incorporated into starch. Furthermore, it is not clear at the moment which enzymes are responsible for the breakdown of starch in vegetative plant organs. In order to address these open questions in starch metabolism, researchers working in Jens Kossmanns in the department headed by Lothar Willmitzer at the Max Planck Institute of Molecular Plan
'"/>

Contact: Jens Kossmann
Kossmann@Mpimp-Golm.MPG.de
+49-331-9772-784
Max-Planck-Gesellschaft
14-May-1998


Page: 1 2 3 4

Related biology news :

1. Inhibition of cathepsin proteases inhibits tumor formation in transgenic mice
2. Inhibition of insulin-like growth factor receptor-1 as promising anticancer therapeutic
3. Inhibition of Borrelia burgdorferi protein may reduce Lyme disease transmission
4. Competitive Inhibition May Enhance Safety Of Minimally Processed Fruits And Vegetables
5. Novel IBD therapeutic approaches reported from Washington Univ., Barcelona, LSU at APS meeting
6. Novel therapeutic bortezomib moves to phase II trial in lung cancer patients
7. Novel approaches to current cellular therapies continue progress toward disease prevention
8. Novel therapies show promise against myeloid leukemia
9. Novel sensors help clear the air
10. Fox Chase Cancer Center study: Novel DNA-repair gene mutation can cause resistance to cancer drugs
11. Novel proteins designed that block inflammation regulator associated with rheumatoid arthritis

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/12/2020)... ... August 12, 2020 , ... Mosio ... are ideal for public health agencies of all sizes. With a focus on ... at-risk individuals find appropriate health care, Mosio helps public health departments automate communications ...
(Date:8/7/2020)... ... August 06, 2020 , ... Nine ... prestigious National STEM Scholar Program, a unique professional development program that provides advanced ... for middle school science teachers nationwide. , Created in partnership between the National ...
(Date:8/3/2020)... ... August 03, 2020 , ... Accumen ... partnership with medical equipment manufacturer, Spectrum Solutions, to provide COVID-19 saliva testing kits ... laboratory supply chain for more than 10 years. Early in the COVID-19 crisis, ...
Breaking Biology News(10 mins):
(Date:8/15/2020)... ... August 13, 2020 , ... True Terpenes , the ... its Scientific Advisory Board (SAB) to research the medical potential of terpenes and the ... when combined with terpenes. The board is focused on expanding the recently launched line ...
(Date:8/12/2020)... ... August 12, 2020 , ... Inc. magazine ... global leader in FDA compliance consulting has been named on its annual Inc. ... list represents a unique look at the most successful companies within the American ...
(Date:7/31/2020)... SCOTTSDALE, Ariz. (PRWEB) , ... July 29, 2020 , ... ... cell joint injections for only $3950. With 50 million stem cells total, patients may ... well stem cell therapy works for arthritic joints (BMC Musculoskelet Disord. 2016). At R3 ...
(Date:7/31/2020)... ... July 29, 2020 , ... Editas Medicine, Inc. (Nasdaq: ... advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene ... strategic partnership whereby Catalent will provide support for the development, manufacturing, and clinical ...
Breaking Biology Technology:
Cached News: